search
Back to results

Algorithmic-Based Evaluation and Treatment Approach for Robotic Gait Training

Primary Purpose

Complete Spinal Cord Injury, Incomplete Spinal Cord Injury, Acquired Brain Injury

Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
ReWalk
EKSO
REX
Sponsored by
The University of Texas Health Science Center, Houston
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Complete Spinal Cord Injury

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Spinal Cord Injury Inclusion Criteria:

  • Male or non-pregnant female
  • ≥18 years of age
  • Chronic (> 6 mo post) injury
  • Diagnosis of spinal cord injury
  • Able to achieve adequate fit within exoskeleton
  • Sufficient range of motion to attain normal, reciprocal gait pattern, and transition from normal sit to stand or stand to sit
  • Weight <220 pounds
  • Intact skin on all surfaces in contact with device and load bearing surfaces
  • Ability to perform informed consent
  • Cognitively intact and able to follow directions and demonstrate learning capability

Spinal Cord Injury Exclusion Criteria:

  • Pregnancy
  • Spinal instability
  • Non-English speaking
  • Unhealed limb or pelvic fractures or any condition restricting weight bearing in limbs
  • Diagnosis of other neurological injury other than SCI such as CVA, MS, ABI, CP
  • Uncontrolled spasticity (≥3 on Modified Ashworth Scale)[21]
  • Colostomy
  • Decreased range of motion or contractures in legs (>10° at hips, knees or ankles)
  • Uncontrolled autonomic dysreflexia
  • Unresolved deep vein thrombosis
  • Inability to tolerate standing due to cardiovascular issues or orthostatic hypotension
  • Severe comorbidities: active infections, heart, lung, or circulatory conditions
  • Pressure sores, impaired skin integrity

Acquired Brain Injury(ABI) Inclusion Criteria:

  • Male or non-pregnant female
  • ≥18 years of age
  • Chronic (> 6 mo post) injury
  • Able to achieve adequate fit within exoskeleton
  • Ability to perform informed consent
  • Sufficient range of motion to attain normal, reciprocal gait pattern, and transition from normal sit to stand or stand to sit
  • Weight <220 pounds
  • Intact skin on all surfaces in contact with device and load bearing surfaces
  • Cognitively intact and able to follow directions and demonstrate learning capability

Acquired Brain Injury(ABI) Exclusion Criteria:

  • Pregnancy
  • Spinal instability
  • Non-English speaking
  • Unhealed limb or pelvic fractures or any condition restricting weight bearing in limbs
  • Diagnosis of other neurological injury other than ABI such as SCI, MS, TBI, CP
  • Decreased range of motion or contractures in legs (>10° at hips, knees or ankles)
  • Inability to tolerate standing due to cardiovascular issues or orthostatic hypotension
  • Pressure sores, impaired skin integrity
  • Uncontrolled spasticity (≥3 on Modified Ashworth Scale)
  • Colostomy
  • Severe comorbidities: active infections, heart, lung, or circulatory conditions
  • Unresolved deep vein thrombosis

Multiple Sclerosis (MS) Inclusion Criteria:

  • Male or non-pregnant female
  • ≥18 years of age
  • Chronic (> 6 mo post) injury
  • Diagnosis of multiple sclerosis
  • Ability to perform informed consent
  • Sufficient range of motion to attain normal, reciprocal gait pattern, and transition from normal sit to stand or stand to sit
  • Weight <220 pounds
  • Able to achieve adequate fit within exoskeleton
  • Intact skin on all surfaces in contact with device and load bearing surfaces
  • Cognitively intact and able to follow directions and demonstrate learning capability

Multiple Sclerosis (MS) Exclusion Criteria:

  • Pregnancy
  • Spinal instability
  • Non-English speaking
  • Unhealed limb or pelvic fractures or any condition restricting weight bearing in limbs
  • Decreased range of motion or contractures in legs (>10° at hips, knees or ankles)
  • Inability to tolerate standing due to cardiovascular issues or orthostatic hypotension
  • Uncontrolled autonomic dysreflexia
  • Unresolved deep vein thrombosis
  • Pressure sores, impaired skin integrity
  • Uncontrolled spasticity (≥3 on Modified Ashworth Scale)
  • Colostomy
  • Severe comorbidities: active infections, heart, lung, or circulatory conditions[23,24]
  • Diagnosis of other neurological injury other than MS such as CVA, SCI, ABI, CP
  • MS Relapse in 3 months prior to recruitment

Able Bodied Inclusion Criteria:

  • Male or non-pregnant female
  • ≥18 years of age
  • Weight <220 pounds
  • Cognitively intact and able to follow directions and demonstrate learning capability[23]
  • Healthy individuals with no history or diagnosis of neurological injury
  • Sufficient range of motion to attain normal, reciprocal gait pattern, and transition from normal sit to stand or stand to sit
  • Able to achieve adequate fit within exoskeleton
  • Intact skin on all surfaces in contact with device and load bearing surfaces
  • Ability to perform informed consent[24]

Able Bodied Exclusion Criteria:

  • Pregnancy
  • Spinal instability
  • Non-English speaking
  • Unhealed limb or pelvic fractures or any condition restricting weight bearing in limbs
  • Diagnosis of neurological injury such as CVA, SCI, ABI, CP, MS
  • Decreased range of motion or contractures in legs (>10° at hips, knees or ankles)
  • Severe comorbidities: active infections, heart, lung, or circulatory conditions
  • Colostomy

Sites / Locations

  • TIRR Memorial HermannRecruiting

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm 5

Arm 6

Arm Type

Experimental

Experimental

Experimental

Experimental

Experimental

Experimental

Arm Label

ReWalk, then EKSO, then REX

ReWalk, then REX, then EKSO

EKSO, then ReWalk, then REX

EKSO, then REX, then ReWalk

REX, then EKSO, then ReWalk

REX, then ReWalk, then EKSO

Arm Description

Subjects will be asked to complete a screening visit, baseline and post assessment for each intervention training (ReWalk, EKSO, REX) and up to 15 training sessions per device.

Subjects will be asked to complete a screening visit, baseline and post assessment for each intervention training (ReWalk, EKSO, REX) and up to 15 training sessions per device.

Subjects will be asked to complete a screening visit, baseline and post assessment for each intervention training (ReWalk, EKSO, REX) and up to 15 training sessions per device.

Subjects will be asked to complete a screening visit, baseline and post assessment for each intervention training (ReWalk, EKSO, REX) and up to 15 training sessions per device.

Subjects will be asked to complete a screening visit, baseline and post assessment for each intervention training (ReWalk, EKSO, REX) and up to 15 training sessions per device.

Subjects will be asked to complete a screening visit, baseline and post assessment for each intervention training (ReWalk, EKSO, REX) and up to 15 training sessions per device.

Outcomes

Primary Outcome Measures

Change in over ground gait speed as assessed by the 10 Meter Walk Test without WRE
The 10 Meter Walk Test (10MWT) will assess subject's self-selected gait speed.
Change in walking endurance as assessed by the 6 Minute Walk Test without WRE
The 6 Minute Walk Test (6MWT) assesses the distance walked in 6 minutes.
Change in muscle activity as assessed by electromyography (EMG) during 10MWT without WRE
Surface EMG sensors will be placed on the skin of subjects' lower extremities during 10MWT.
Change in muscle activity as assessed by electromyography (EMG) during 6MWT without WRE
Surface EMG sensors will be placed on the skin of subjects' lower extremities during 6MWT.
Change in energy expenditure as assessed by oxygen consumption during 10MWT without WRE
Oxygen consumption will be calculated on a breath-by-breath basis measured by a portable metabolic system (Cosmed K4b2). This task will be performed during the 10MWT.
Change in energy expenditure as assessed by oxygen consumption during 6MWT without WRE
Oxygen consumption will be calculated on a breath-by-breath basis measured by a portable metabolic system (Cosmed K4b2). This task will be performed during the 6MWT.
Change in gait kinematics as assessed by lower extremity joint excursion without WRE
Infrared light emitting diode markers will be attached to bilateral lower extremities. The marker data will be recorded using motion capture system.
Change in gait kinematics as assessed by lower extremity joint angular velocities without WRE
Infrared light emitting diode markers will be attached to bilateral lower extremities. The marker data will be recorded using motion capture system.

Secondary Outcome Measures

Bone mineral density as assessed by whole body scan
Subjects will undergo whole body bone scan according to standardized protocols.
Cognitive impairment as assessed by Folstein Mini Mental State Examination
Folstein Mini Mental State Examination provides information about orientation, attention, learning, calculation, delayed recall, and construction.
Lower Extremity Muscle Strength as assessed by using a force gauge such as a handheld dynamometer
We will measure lower extremity muscle strength using a force gauge such as a handheld dynamometer.
Spasticity as assessed by the Modified Ashworth Scale (MAS)
The Modified Ashworth Scale will be used to measure spasticity in lower limb.
Range of motion for lower extremity joints as assessed by manual examination
Range of joint motion of bilateral hip, knee and ankle joints. Subject will lie down on an examination table.
Stability during the maximum distance an individual can reach forward from a seated position as assessed by Modified Functional Reach (MFR)
Assesses a patient's stability by measuring the maximum distance an individual can reach forward from a seated position.
Walking ability in ambulatory individuals with SC as assessed by Spinal Cord Injury Functional Ambulation Inventory (SCI-FAI):
Assesses functional walking ability in ambulatory individuals with SCI.
Amount of physical assistance needed for walking following paralysis resulted from SCI as assessed by Walking Index of Spinal Cord Injury (WISCI-II)
This test is performed by SCI population.
Motor recovery after stroke as assessed by Fugl-Meyer Assessment
Evaluates and measures recovery in post-stroke hemiplegic individuals.
Confidence in performing various ambulatory activities as assessed by Activities-Specific Balance Confidence Scale
Measure of confidence in performing various ambulatory activities without falling or experiencing a sense of unsteadiness. This is performed in ABI and MS population.
User feedback as assessed by a questionnaire
A questionnaire will be administered to allow participants to provide feedback regarding their experiences during intervention.
Over ground gait speed as assessed by the 10 Meter Walk Test while wearing WRE
The 10 Meter Walk Test (10MWT) will assess subject's self-selected gait speed. After WRE training has been completed, subjects will perform 10MWT while ambulating in the WRE.
Change in walking endurance as assessed by the 6 Minute Walk Test while wearing WRE
The 6 Minute Walk Test (6MWT) assesses the distance walked in 6 minutes. After WRE training has been completed, subjects will perform 6MWT while ambulating in the WRE.
Change in muscle activity as assessed by electromyography (EMG) during 10MWT while wearing WRE
Surface EMG sensors will be placed on the skin of subjects' lower extremities during 10MWT. After WRE training has been completed, subjects will be assessed by EMG during the 10MWT while ambulating in the WRE.
Change in muscle activity as assessed by electromyography (EMG) during 6MWT while wearing WRE
Surface EMG sensors will be placed on the skin of subjects' lower extremities during 6MWT. After WRE training has been completed, subjects will be assessed by EMG during the 6MWT while ambulating in the WRE.
Change in energy expenditure as assessed by oxygen consumption during 10MWT while wearing WRE
Oxygen consumption will be calculated on a breath-by-breath basis measured by a portable metabolic system (Cosmed K4b2). This task will be performed during the 10MWT. After WRE training has been completed, oxygen consumption will be assessed in subjects during the 10MWT while ambulating in the WRE.
Change in energy expenditure as assessed by oxygen consumption during 6MWT while wearing WRE
Oxygen consumption will be calculated on a breath-by-breath basis measured by a portable metabolic system (Cosmed K4b2). This task will be performed during the 6MWT. After WRE training has been completed, oxygen consumption will be assessed in subjects during the 10MWT while ambulating in the WRE.
Change in gait kinematics as assessed by lower extremity joint excursion while wearing WRE
Infrared light emitting diode markers will be attached to bilateral lower extremities. The marker data will be recorded using motion capture system. After WRE training has been completed, subjects will be assessed while ambulating in the WRE.
Change in gait kinematics as assessed by lower extremity joint angular velocities while wearing WRE
Infrared light emitting diode markers will be attached to bilateral lower extremities. The marker data will be recorded using motion capture system. After WRE training has been completed, subjects will be assessed while ambulating in the WRE.
Change in H-reflex of soleus muscle as assessed by electromyography (EMG)
The tibialis nerve will be stimulated, and the size of each H-reflex will be measured as the peak-to-peak amplitude of the non-rectified EMG trace.

Full Information

First Posted
February 15, 2017
Last Updated
May 19, 2022
Sponsor
The University of Texas Health Science Center, Houston
search

1. Study Identification

Unique Protocol Identification Number
NCT03057652
Brief Title
Algorithmic-Based Evaluation and Treatment Approach for Robotic Gait Training
Official Title
Algorithmic-Based Evaluation and Treatment Approach for Robotic Gait Training
Study Type
Interventional

2. Study Status

Record Verification Date
May 2022
Overall Recruitment Status
Recruiting
Study Start Date
March 2016 (Actual)
Primary Completion Date
December 2023 (Anticipated)
Study Completion Date
December 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
The University of Texas Health Science Center, Houston

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this study is to develop an algorithmic-based evaluation and treatment approach for wearable robotic exoskeleton (WRE) gait training for patients with neurological conditions.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Complete Spinal Cord Injury, Incomplete Spinal Cord Injury, Acquired Brain Injury, Multiple Sclerosis

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Model Description
Each of the participants will receive training with each of the 3 wearable robotic exoskeletons (WRE) examined in this study, and the order of receipt will be randomized.
Masking
None (Open Label)
Allocation
Randomized
Enrollment
75 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
ReWalk, then EKSO, then REX
Arm Type
Experimental
Arm Description
Subjects will be asked to complete a screening visit, baseline and post assessment for each intervention training (ReWalk, EKSO, REX) and up to 15 training sessions per device.
Arm Title
ReWalk, then REX, then EKSO
Arm Type
Experimental
Arm Description
Subjects will be asked to complete a screening visit, baseline and post assessment for each intervention training (ReWalk, EKSO, REX) and up to 15 training sessions per device.
Arm Title
EKSO, then ReWalk, then REX
Arm Type
Experimental
Arm Description
Subjects will be asked to complete a screening visit, baseline and post assessment for each intervention training (ReWalk, EKSO, REX) and up to 15 training sessions per device.
Arm Title
EKSO, then REX, then ReWalk
Arm Type
Experimental
Arm Description
Subjects will be asked to complete a screening visit, baseline and post assessment for each intervention training (ReWalk, EKSO, REX) and up to 15 training sessions per device.
Arm Title
REX, then EKSO, then ReWalk
Arm Type
Experimental
Arm Description
Subjects will be asked to complete a screening visit, baseline and post assessment for each intervention training (ReWalk, EKSO, REX) and up to 15 training sessions per device.
Arm Title
REX, then ReWalk, then EKSO
Arm Type
Experimental
Arm Description
Subjects will be asked to complete a screening visit, baseline and post assessment for each intervention training (ReWalk, EKSO, REX) and up to 15 training sessions per device.
Intervention Type
Device
Intervention Name(s)
ReWalk
Intervention Description
ReWalk is a type of wearable robotic exoskeleton (WRE). Subjects will be randomly assigned the order of participation in the exoskeleton devices. ReWalk training sessions will be scheduled for one hour to include don/doff of device, sit to stand, standing balance and walking. ReWalk phase will require 2 hours pre and 2 hours post training for outcome measurement assessments, plus a minimum of 5 training sessions, with the possibility of up to 15 training sessions to reach a minimal assistance level. The total time commitment for each subject will range from 14-20 weeks and cover 27-72 hours.
Intervention Type
Device
Intervention Name(s)
EKSO
Intervention Description
EKSO is a type of wearable robotic exoskeleton (WRE). Subjects will be randomly assigned the order of participation in the exoskeleton devices. EKSO training sessions will be scheduled for one hour to include don/doff of device, sit to stand, standing balance and walking. EKSO phase will require 2 hours pre and 2 hours post training for outcome measurement assessments, plus a minimum of 5 training sessions, with the possibility of up to 15 training sessions to reach a minimal assistance level. The total time commitment for each subject will range from 14-20 weeks and cover 27-72 hours.
Intervention Type
Device
Intervention Name(s)
REX
Intervention Description
REX is a type of wearable robotic exoskeleton (WRE). Subjects will be randomly assigned the order of participation in the exoskeleton devices. REX training sessions will be scheduled for one hour to include don/doff of device, sit to stand, standing balance and walking. REX phase will require 2 hours pre and 2 hours post training for outcome measurement assessments, plus a minimum of 5 training sessions, with the possibility of up to 15 training sessions to reach a minimal assistance level. The total time commitment for each subject will range from 14-20 weeks and cover 27-72 hours.
Primary Outcome Measure Information:
Title
Change in over ground gait speed as assessed by the 10 Meter Walk Test without WRE
Description
The 10 Meter Walk Test (10MWT) will assess subject's self-selected gait speed.
Time Frame
within one week before start of WRE training, within 2 weeks after start of WRE training
Title
Change in walking endurance as assessed by the 6 Minute Walk Test without WRE
Description
The 6 Minute Walk Test (6MWT) assesses the distance walked in 6 minutes.
Time Frame
within one week before start of WRE training, within 2 weeks after start of WRE training
Title
Change in muscle activity as assessed by electromyography (EMG) during 10MWT without WRE
Description
Surface EMG sensors will be placed on the skin of subjects' lower extremities during 10MWT.
Time Frame
within one week before start of WRE training, within 2 weeks after start of WRE training
Title
Change in muscle activity as assessed by electromyography (EMG) during 6MWT without WRE
Description
Surface EMG sensors will be placed on the skin of subjects' lower extremities during 6MWT.
Time Frame
within one week before start of WRE training, within 2 weeks after start of WRE training
Title
Change in energy expenditure as assessed by oxygen consumption during 10MWT without WRE
Description
Oxygen consumption will be calculated on a breath-by-breath basis measured by a portable metabolic system (Cosmed K4b2). This task will be performed during the 10MWT.
Time Frame
within one week before start of WRE training, within 2 weeks after start of WRE training
Title
Change in energy expenditure as assessed by oxygen consumption during 6MWT without WRE
Description
Oxygen consumption will be calculated on a breath-by-breath basis measured by a portable metabolic system (Cosmed K4b2). This task will be performed during the 6MWT.
Time Frame
within one week before start of WRE training, within 2 weeks after start of WRE training
Title
Change in gait kinematics as assessed by lower extremity joint excursion without WRE
Description
Infrared light emitting diode markers will be attached to bilateral lower extremities. The marker data will be recorded using motion capture system.
Time Frame
within one week before start of WRE training, within 2 weeks after start of WRE training
Title
Change in gait kinematics as assessed by lower extremity joint angular velocities without WRE
Description
Infrared light emitting diode markers will be attached to bilateral lower extremities. The marker data will be recorded using motion capture system.
Time Frame
within one week before start of WRE training, within 2 weeks after start of WRE training
Secondary Outcome Measure Information:
Title
Bone mineral density as assessed by whole body scan
Description
Subjects will undergo whole body bone scan according to standardized protocols.
Time Frame
within one month before start of WRE training
Title
Cognitive impairment as assessed by Folstein Mini Mental State Examination
Description
Folstein Mini Mental State Examination provides information about orientation, attention, learning, calculation, delayed recall, and construction.
Time Frame
within one month before start of WRE training
Title
Lower Extremity Muscle Strength as assessed by using a force gauge such as a handheld dynamometer
Description
We will measure lower extremity muscle strength using a force gauge such as a handheld dynamometer.
Time Frame
within one month before start of WRE training
Title
Spasticity as assessed by the Modified Ashworth Scale (MAS)
Description
The Modified Ashworth Scale will be used to measure spasticity in lower limb.
Time Frame
within one month before start of WRE training
Title
Range of motion for lower extremity joints as assessed by manual examination
Description
Range of joint motion of bilateral hip, knee and ankle joints. Subject will lie down on an examination table.
Time Frame
within one month before start of WRE training
Title
Stability during the maximum distance an individual can reach forward from a seated position as assessed by Modified Functional Reach (MFR)
Description
Assesses a patient's stability by measuring the maximum distance an individual can reach forward from a seated position.
Time Frame
within one month before start of WRE training
Title
Walking ability in ambulatory individuals with SC as assessed by Spinal Cord Injury Functional Ambulation Inventory (SCI-FAI):
Description
Assesses functional walking ability in ambulatory individuals with SCI.
Time Frame
within one month before start of WRE training
Title
Amount of physical assistance needed for walking following paralysis resulted from SCI as assessed by Walking Index of Spinal Cord Injury (WISCI-II)
Description
This test is performed by SCI population.
Time Frame
within one month before start of WRE training
Title
Motor recovery after stroke as assessed by Fugl-Meyer Assessment
Description
Evaluates and measures recovery in post-stroke hemiplegic individuals.
Time Frame
within one month before start of WRE training
Title
Confidence in performing various ambulatory activities as assessed by Activities-Specific Balance Confidence Scale
Description
Measure of confidence in performing various ambulatory activities without falling or experiencing a sense of unsteadiness. This is performed in ABI and MS population.
Time Frame
within one month before start of WRE training
Title
User feedback as assessed by a questionnaire
Description
A questionnaire will be administered to allow participants to provide feedback regarding their experiences during intervention.
Time Frame
within one month before start of WRE training
Title
Over ground gait speed as assessed by the 10 Meter Walk Test while wearing WRE
Description
The 10 Meter Walk Test (10MWT) will assess subject's self-selected gait speed. After WRE training has been completed, subjects will perform 10MWT while ambulating in the WRE.
Time Frame
within one month before start of WRE training
Title
Change in walking endurance as assessed by the 6 Minute Walk Test while wearing WRE
Description
The 6 Minute Walk Test (6MWT) assesses the distance walked in 6 minutes. After WRE training has been completed, subjects will perform 6MWT while ambulating in the WRE.
Time Frame
within one month before start of WRE training
Title
Change in muscle activity as assessed by electromyography (EMG) during 10MWT while wearing WRE
Description
Surface EMG sensors will be placed on the skin of subjects' lower extremities during 10MWT. After WRE training has been completed, subjects will be assessed by EMG during the 10MWT while ambulating in the WRE.
Time Frame
within one month before start of WRE training
Title
Change in muscle activity as assessed by electromyography (EMG) during 6MWT while wearing WRE
Description
Surface EMG sensors will be placed on the skin of subjects' lower extremities during 6MWT. After WRE training has been completed, subjects will be assessed by EMG during the 6MWT while ambulating in the WRE.
Time Frame
within one month before start of WRE training
Title
Change in energy expenditure as assessed by oxygen consumption during 10MWT while wearing WRE
Description
Oxygen consumption will be calculated on a breath-by-breath basis measured by a portable metabolic system (Cosmed K4b2). This task will be performed during the 10MWT. After WRE training has been completed, oxygen consumption will be assessed in subjects during the 10MWT while ambulating in the WRE.
Time Frame
within one month before start of WRE training
Title
Change in energy expenditure as assessed by oxygen consumption during 6MWT while wearing WRE
Description
Oxygen consumption will be calculated on a breath-by-breath basis measured by a portable metabolic system (Cosmed K4b2). This task will be performed during the 6MWT. After WRE training has been completed, oxygen consumption will be assessed in subjects during the 10MWT while ambulating in the WRE.
Time Frame
within one month before start of WRE training
Title
Change in gait kinematics as assessed by lower extremity joint excursion while wearing WRE
Description
Infrared light emitting diode markers will be attached to bilateral lower extremities. The marker data will be recorded using motion capture system. After WRE training has been completed, subjects will be assessed while ambulating in the WRE.
Time Frame
within one month before start of WRE training
Title
Change in gait kinematics as assessed by lower extremity joint angular velocities while wearing WRE
Description
Infrared light emitting diode markers will be attached to bilateral lower extremities. The marker data will be recorded using motion capture system. After WRE training has been completed, subjects will be assessed while ambulating in the WRE.
Time Frame
within one month before start of WRE training
Title
Change in H-reflex of soleus muscle as assessed by electromyography (EMG)
Description
The tibialis nerve will be stimulated, and the size of each H-reflex will be measured as the peak-to-peak amplitude of the non-rectified EMG trace.
Time Frame
within one week before start of WRE training, within 2 weeks after start of WRE training

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Spinal Cord Injury Inclusion Criteria: Male or non-pregnant female ≥18 years of age Chronic (> 6 mo post) injury Diagnosis of spinal cord injury Able to achieve adequate fit within exoskeleton Sufficient range of motion to attain normal, reciprocal gait pattern, and transition from normal sit to stand or stand to sit Weight <220 pounds Intact skin on all surfaces in contact with device and load bearing surfaces Ability to perform informed consent Cognitively intact and able to follow directions and demonstrate learning capability Spinal Cord Injury Exclusion Criteria: Pregnancy Spinal instability Non-English speaking Unhealed limb or pelvic fractures or any condition restricting weight bearing in limbs Diagnosis of other neurological injury other than SCI such as CVA, MS, ABI, CP Uncontrolled spasticity (≥3 on Modified Ashworth Scale)[21] Colostomy Decreased range of motion or contractures in legs (>10° at hips, knees or ankles) Uncontrolled autonomic dysreflexia Unresolved deep vein thrombosis Inability to tolerate standing due to cardiovascular issues or orthostatic hypotension Severe comorbidities: active infections, heart, lung, or circulatory conditions Pressure sores, impaired skin integrity Acquired Brain Injury(ABI) Inclusion Criteria: Male or non-pregnant female ≥18 years of age Chronic (> 6 mo post) injury Able to achieve adequate fit within exoskeleton Ability to perform informed consent Sufficient range of motion to attain normal, reciprocal gait pattern, and transition from normal sit to stand or stand to sit Weight <220 pounds Intact skin on all surfaces in contact with device and load bearing surfaces Cognitively intact and able to follow directions and demonstrate learning capability Acquired Brain Injury(ABI) Exclusion Criteria: Pregnancy Spinal instability Non-English speaking Unhealed limb or pelvic fractures or any condition restricting weight bearing in limbs Diagnosis of other neurological injury other than ABI such as SCI, MS, TBI, CP Decreased range of motion or contractures in legs (>10° at hips, knees or ankles) Inability to tolerate standing due to cardiovascular issues or orthostatic hypotension Pressure sores, impaired skin integrity Uncontrolled spasticity (≥3 on Modified Ashworth Scale) Colostomy Severe comorbidities: active infections, heart, lung, or circulatory conditions Unresolved deep vein thrombosis Multiple Sclerosis (MS) Inclusion Criteria: Male or non-pregnant female ≥18 years of age Chronic (> 6 mo post) injury Diagnosis of multiple sclerosis Ability to perform informed consent Sufficient range of motion to attain normal, reciprocal gait pattern, and transition from normal sit to stand or stand to sit Weight <220 pounds Able to achieve adequate fit within exoskeleton Intact skin on all surfaces in contact with device and load bearing surfaces Cognitively intact and able to follow directions and demonstrate learning capability Multiple Sclerosis (MS) Exclusion Criteria: Pregnancy Spinal instability Non-English speaking Unhealed limb or pelvic fractures or any condition restricting weight bearing in limbs Decreased range of motion or contractures in legs (>10° at hips, knees or ankles) Inability to tolerate standing due to cardiovascular issues or orthostatic hypotension Uncontrolled autonomic dysreflexia Unresolved deep vein thrombosis Pressure sores, impaired skin integrity Uncontrolled spasticity (≥3 on Modified Ashworth Scale) Colostomy Severe comorbidities: active infections, heart, lung, or circulatory conditions[23,24] Diagnosis of other neurological injury other than MS such as CVA, SCI, ABI, CP MS Relapse in 3 months prior to recruitment Able Bodied Inclusion Criteria: Male or non-pregnant female ≥18 years of age Weight <220 pounds Cognitively intact and able to follow directions and demonstrate learning capability[23] Healthy individuals with no history or diagnosis of neurological injury Sufficient range of motion to attain normal, reciprocal gait pattern, and transition from normal sit to stand or stand to sit Able to achieve adequate fit within exoskeleton Intact skin on all surfaces in contact with device and load bearing surfaces Ability to perform informed consent[24] Able Bodied Exclusion Criteria: Pregnancy Spinal instability Non-English speaking Unhealed limb or pelvic fractures or any condition restricting weight bearing in limbs Diagnosis of neurological injury such as CVA, SCI, ABI, CP, MS Decreased range of motion or contractures in legs (>10° at hips, knees or ankles) Severe comorbidities: active infections, heart, lung, or circulatory conditions Colostomy
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Shuo-Hsiu Chang, PT, PhD
Phone
713-799-7016
Email
shuo-hsiu.chang@uth.tmc.edu
First Name & Middle Initial & Last Name or Official Title & Degree
Ruta Paranjape, MS, CCRP
Phone
713-799-6976
Email
Ruta.Paranjape@uth.tmc.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Shuo-Hsiu Chang, PT, PhD
Organizational Affiliation
The University of Texas Health Science Center, Houston
Official's Role
Principal Investigator
Facility Information:
Facility Name
TIRR Memorial Hermann
City
Houston
State/Province
Texas
ZIP/Postal Code
77030
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Shuo-Hsiu Chang, PT, PhD
Phone
713-799-7016
Email
Shuo-Hsiu.Chang@uth.tmc.edu
First Name & Middle Initial & Last Name & Degree
Marcie Kern, PT, MS
Phone
713-799-6995
Email
Marcie.Kern@memorialhermann.org

12. IPD Sharing Statement

Citations:
PubMed Identifier
33752175
Citation
Zhu F, Kern M, Fowkes E, Afzal T, Contreras-Vidal JL, Francisco GE, Chang SH. Effects of an exoskeleton-assisted gait training on post-stroke lower-limb muscle coordination. J Neural Eng. 2021 Jun 4;18(4). doi: 10.1088/1741-2552/abf0d5.
Results Reference
derived

Learn more about this trial

Algorithmic-Based Evaluation and Treatment Approach for Robotic Gait Training

We'll reach out to this number within 24 hrs